Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
Nancy Monson

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

Nancy Monson, Ph.D.

 Details of Research

Biographical Sketch Details of Research Personal Overview How to Contact
Nancy Monson
Name:
  Nancy Lee Monson, Ph.D.
Academic Title:
  Assistant Professor
Primary Appointment:
  Neurology
Secondary Appointment:
  Immunology
School:
  Graduate School of Biomedical Sciences
Southwestern Medical School
Degree Program:
  Immunology
Non-degree Program:
  STARS
SURF
Department Website:
  Department of Neurology
Lab Website:
  Monson Lab
Email:
  Nancy Monson, Ph.D.

 RESEARCH OVERVIEW
 
Multiple Sclersosis (MS) is an inflammatory, demyelinating disease of the Central Nervous System (CNS) which likely involves an autoimmune mechanism directed agains self-myelin associated antigens. There is substantial evidence suggesting that B cells are involved in the pathogenesis of MS. In order to define the Ig repertoires in the CSF of MS patients and identify Ig’s from clonally expanded B cells using Single Cell PCR. We then plan to explore the antigenic specificity of these unique Ig rearrangements by cloning both the heavy and light chain segments into an expression vector, isolating the resultant Fab fragments, and testing them for their antigenic specificity. We can also use PCR to track the persistence of these clones in the CSF of these original MS patients and determine whether we can detect these clones in their peripheral blood as well as in other MS patients. These studies are necessary in order to directly ascertain the potential role of B cells in the pathogenicity of MS, and ultimately will allow us to explore the possibility of generating specific immunotherapies directed against these clonally expanded B cells in the future.
 
 RESEARCH INTERESTS
 
Multiple Sclerosis
B cell Biology
Autoimmune Disease
Translational Research
Antibodies
 
 RECENT PUBLICATIONS
 
37. Stuve O, Marra CM, Cravens PD, Singh MP, Hu W, Lovett-Racke A, Monson NL, Phillips JT, Tervaert JW, Nash RA, Hartung HP, Kieseier BC, Racke MM, Frohman EM, Hemmer B., "Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions" Arch Neurol, 64:169-76, 2007
36. Harp C., Lee J., Lambracht-Washington D., Frohman E., Racke M.K., and Monson NL, "Cerebrospinal fluid B cells from Multiple Sclerosis patients are subject to normal germinal center selection" J Neuroimmunol, 183:189, 2007
35. Lambracht-Washington D., O?Connor K.C., Jowdry A., Ward E.S., Rula K., Frohman E., Racke M.K., and Monson NL, "Antigen Specificity of Clonally Expanded and Receptor Edited Cerebrospinal Fluid B cells from Patients with Relapsing Remitting MS" J. Neuroimmunol, 186:164-176, 2007
Martin, Maria del Pilar and Monson NL, "Potential Role of Humoral Immunity in the Pathogenesis of Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE)" Frontiers in Bioscience, 12:735-2749, 2007
33. Stuve O, Marra C, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Gran?Maison F, Hemmer B, Monson NL, Racke MK, "Altered CD4:CD8 T cell Ratios in Cerebrospinal fluid of Natalizumab treated Multiple Sclerosis Patients" Archives of Neurology, 63:1383-1387, 2006
 
 SIGNIFICANT PUBLICATIONS
 
32. Stuve O, Marra C, Jerome K, Cook L, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Hemmer B, Monson NL and Racke MK, "Immune Surveillance in Multiple Sclerosis Patients Treated with Natalizumab" Ann Neurol, 59:743-747, 2006
Paula S, Monson NL, Ball WJ, Jr, "Molecular Modeling of Cardiac Glycoside Binding by the Monoclonal Human Sequence Antibody 1B3" Proteins, 60:382-391, 2005
30. Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke MK., "Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions" Arch Neurol, 62(9):1345-56, 2005
29. Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK, "Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis" Arch Neurol, 62:258-64, 2005
28. Monson NL, Brezinschek HP, Brezinschek RI, Mobley A, Vaughan GK, Frohman EM, Racke MK, Lipsky PE, "Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients" J Neuroimmunol, 158:170-81, 2005
 
Point and right click (click and hold for Mac users) your mouse on and select "Save this link (or target) as..." option to save the file to your local computer.